- Aceclofenac IP/BP/USP
- Glipizide ip/bp
- Methyl nicotinate IP
- Dexibuprofen ip/bp
- Metronidazole ip/bp
- Voglibose IP
- Artesunate ip/bp
- Lumefantrine IP
- Tazobactam SODIUM
- Racecadotril ip
- Loxoprofen ip
- Mefloquine ip
- Tinidazole
- Meloxicam IP
- Trimethoprim ip
- Naproxen sodium ip/bp
- Clotrimazole ip
- Fluconazole ip
- Piroxicam ip/bp
- Itraconazole IP/BP
- Diacerein
- Doxycycline ip
- Empagliflozin
Tamsulosin ip
Used in the treatment of signs and symptoms of benign prostatic hyperplasia (reduction in urinary obstruction and relief of associated manifestations such as hesitancy, terminal dribbling of urine, interrupted or weak stream…etc.)
Tamsulosin is a selective antagonist at alpha-1A and alpha-1B-adrenoceptors in the prostate, prostatic capsule, prostatic urethra, and bladder neck. At least three discrete alpha1-adrenoceptor subtypes have been identified: alpha-1A, alpha-1B and alpha-1D; their distribution differs between human organs and tissue. Approximately 70% of the alpha1-receptors in human prostate are of the alpha-1A subtype. Blockage of these receptors causes relaxation of smooth muscles in the bladder neck and prostate, and thus decreases urinary outflow resistance in men.